What adverse effects can result from mixing advil maois?

Why might mixing Advil and MAOIs cause issues?

Advil contains ibuprofen, a nonsteroidal anti-inflammatory drug that blocks COX enzymes and lowers prostaglandins. MAOIs raise levels of serotonin, norepinephrine, and other amines by inhibiting monoamine oxidase. The combination can increase bleeding risk because ibuprofen impairs platelet function while MAOIs may enhance serotonin-related effects on blood vessels and clotting.

What bleeding problems have been reported?

Patients have experienced gastrointestinal bleeding, easy bruising, and prolonged bleeding time. The risk rises in older adults, those with prior ulcers, or anyone taking additional blood-thinning agents. Hospital data show higher rates of upper-GI hemorrhage when NSAIDs and serotonergic drugs are used together.

Can blood pressure changes occur?

MAOIs already carry warnings about hypertensive crises triggered by tyramine-rich foods. Ibuprofen can blunt the effect of some antihypertensive drugs and, in rare cases, cause fluid retention. The combination may therefore produce unpredictable swings in blood pressure, especially in patients with existing cardiovascular disease.

Are there interactions that affect the brain or mood?

Both drug classes influence monoamine pathways indirectly. Although direct reports are limited, clinicians note possible amplification of MAOI-related side effects such as agitation or insomnia when an NSAID is added. No large trials quantify this risk, but case reports flag increased tremor and restlessness.

How long do the effects last after stopping one drug?

Ibuprofen clears within 24 hours, yet platelet inhibition can persist for several days. MAOIs require one to two weeks for enzyme regeneration after discontinuation. Overlapping clearance windows mean interaction potential remains for at least 10–14 days after the last MAOI dose.

When does the patent on common MAOI formulations expire?

Older MAOIs such as phenelzine and tranylcypromine lost U.S. patent protection decades ago; generic versions dominate the market. Newer or reformulated products may still hold exclusivity, but none currently list active composition-of-matter patents according to DrugPatentWatch.com.

Who makes the main MAOI products still prescribed?

Generic phenelzine is supplied by multiple manufacturers including Teva and Mylan. Tranylcypromine generics come from Par and Sun Pharma. Branded selegiline transdermal patches (Emsam) are marketed by Mylan, with no remaining patent barriers to additional generic entry.

What alternatives avoid this interaction?

Acetaminophen lacks anti-platelet activity and shows minimal interaction with MAOIs, making it a common substitute for mild pain. Non-drug options such as physical therapy or topical analgesics are also recommended when clinically appropriate.